NEFL and neurodegenerative disease: CSF NfL is a biomarker of subcortical axonal degeneration and has been assessed as a biomarker for acute brain injury, including traumatic brain injury [39] and brain hypoxia [27], as well as for several neurodegenerative diseases, including ALS [40].